Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

, WFC

Wells Fargo

$55.57

0.34 (0.62%)

16:21
09/20/18
09/20
16:21
09/20/18
16:21

Fly Intel: Wall Street's top stories for Thursday

Stocks opened in positive territory following a report China would ease import prices and work on making itself more open to foreign investment. The market tacked on gains during the morning while the Dow and S&P each eclipsed their all-time highs. The day's economic data was also favorable, suggesting the economy remains a tailwind. ECONOMIC EVENTS: In the U.S., jobless claims fell 3,000 to 201,000 in the week ended September 15, marking a third week that initial claims make a new 48-year low. The leading economic indicator index rose 0.4% to 111.2 in August, which was another new record high. Existing home sales were flat at an annual rate of 5.34M in August, breaking a string of four consecutive monthly declines. The Philly Fed index bounced 11.0 points to 22.9 in September, erasing most of the 13.8 point drop seen last month. COMPANY NEWS: Amazon (AMZN) shares rose about 1% after the company unveiled a litany of Alexa-based products at a company event. Among the new products shown were an all-new Echo Dot, all-new Echo Plus, all-new Echo Show, and the Echo Auto, a device that brings Alexa capabilities to cars. In addition, the company unveiled a new subwoofer speaker called the Echo Sub as well as the AmazonBasics Microwave... Wells Fargo (WFC) was in focus after CEO Tim Sloan said he sees company headcount decreasing 5%-10% in the next three years. Additionally, Wells Fargo chair Betsy Duke told CNBC that a New York Post report that the bank approached Gary Cohn to become its next CEO to replace Sloan is "completely false"... General Electric (GE) fell 3% after GE Power CEO Russell Stokes said in a blog post on LinkedIn that the company recently identified an "oxidation issue" that impacts the lifespan of blades in its HA-Class turbines... Disney (DIS) announced that ESPN+, its direct-to-consumer subscription streaming service, has surpassed one million paying subscribers in just over five months since its April 2018 launch. Meanwhile, the company is going to have its fight for Sky (SKYAY) decided this weekend as the U.K.'s Takeover Panel said it will commence a one-day auction for the British television service. Each of Sky, Comcast (CMCSA), 21st Century Fox (FOXA), and Disney, which is acting in concert with Fox, has agreed to the terms of the auction procedure, the Takeover Panel said... Shares of Under Armour (UAA) closed 6.5% higher after the company provided an update on its restructuring plan and announced a roughly 3% cut to its workforce. MAJOR MOVERS: Among the noteworthy gainers was Corbus Pharmaceuticals (CRBP), which surged over 53% higher after the company licensed the exclusive worldwide rights to develop, manufacture and market drug candidates from more than 600 compounds targeting the endocannabinoid system and CNBC's Jim Cramer said that the company will be appearing tonight on his "Mad Money" program to discuss its cannabis plans. Also higher was Amicus (FOLD), which gained 7% after it acquired a gene therapy portfolio of ten AAV programs for $100M. Among the notable losers was Stitch Fix (SFIX), which dropped 11.5% after Piper Jaffray analyst Erinn Murphy downgraded the stock to Neutral from Overweight. Also lower were Thor Industries (THO) and Red Hat (RHT), which fell a respective 13% and 6% after reporting quarterly results. INDEXES: The Dow rose 251.22, or 0.95%, to 26,656.98, the Nasdaq gained 78.19, or 0.98%, to 8,028.23, and the S&P 500 advanced 22.80, or 0.78%, to 2,930.75.

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

WFC

Wells Fargo

$55.57

0.34 (0.62%)

GE

General Electric

$12.47

-0.39 (-3.03%)

DIS

Disney

$111.62

1.74 (1.58%)

SKYAY

Sky

$0.00

(0.00%)

CMCSA

Comcast

$37.81

0.49 (1.31%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$44.20

-0.05 (-0.11%)

FOXA

21st Century Fox

$44.59

-0.01 (-0.02%)

UAA

Under Armour

$20.01

1.26 (6.72%)

UA

Under Armour

$18.16

0.88 (5.09%)

CRBP

Corbus Pharmaceuticals

$7.90

2.75 (53.40%)

FOLD

Amicus

$12.64

0.84 (7.12%)

SFIX

Stitch Fix

$41.65

-5.56 (-11.78%)

THO

Thor Industries

$91.77

-13.95 (-13.20%)

RHT

Red Hat

$134.06

-9.32 (-6.50%)

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 01

    Oct

  • 01

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Nov

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

AMZN Amazon.com
$1,944.26

17.99 (0.93%)

09/20/18
BARD
09/20/18
NO CHANGE
Target $2100
BARD
Outperform
Amazon could add $6B in annual revenue with 3,000 stores, says Baird
The reported expansion of Amazon Go convenience stores is an "inevitable step" for Amazon.com (AMZN) to scale local services, retail technology, and customer data, Baird analyst Colin Sebastian tells investors in a research note after Bloomberg reported the company could open 3,000 cashierless stores by 2021. Using Casey's General Stores (CASY) as a comparison, 3,000 Go stores could translate into at least $3.0B-$6.0B and $1.0B-$2.0B of annual revenue and gross profit contribution, respectively, Sebastian adds, citing his estimates. However, the analyst notes that his initial checks also suggest prices at the Chicago Go location are 10%-25% lower than competing convenience stores. Further, the significant technology costs associated with each location could represent a drag on Amazon's profitability and free cash flow as the pace of store build-out ramps, Sebastian says. Nonetheless, he believes a cashierless experience in grocery would represent a "differentiating shopping experience for consumers" as well as a "significant opportunity" to increase Amazon's share in the $800B U.S. grocery market. Sebastian keeps an Outperform rating on Amazon shares with a $2,100 price target. The stock closed yesterday down 1%, or $14.63, to $1,926.42.
09/20/18
ARGS
09/20/18
NO CHANGE
Target $2250
ARGS
Buy
Amazon.com price target raised to $2,250 from $2,100 at Argus
Argus analyst Jim Kelleher raised his price target on Amazon (AMZN) to $2,250 and kept his Buy rating, saying the company has become the most popular digital advertising program behind Facebook (FB) and Alphabet (GOOGL). The analyst also expects Amazon to have another strong holiday season, with online retail growth outpacing the industry, growth of the Amazon Prime membership, and increasing engagement of 3rd party merchants. Kelleher maintains his view of Amazon as a "true multi-industry disruptor", also raising his FY18 GAAP EPS target to $16.70 from $15.23 and FY19 to $25.69 from $23.02.
09/20/18
09/20/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BAIRD UPGRADES CATERPILLAR TO OUTPERFORM: Baird analyst Mig Dobre upgraded Caterpillar (CAT) to Outperform from Neutral. The analyst believes demand growth should continue into 2019. While some markets like China are close to peak, most of its demand is still at or below mid-cycle levels, said Dobre, who raised his price target to $191 from $155 on Caterpillar shares. Caterpiller is up 1.5% in late morning trading. PIPER CUTS STITCH FIX TO NEUTRAL: Piper Jaffray analyst Erinn Murphy downgraded Stitch Fix (SFIX) to Neutral while raising her price target for the shares to $43 from $29. The analyst cited valuation for the downgrade. With shares nearing $50, market expectations do not provide any margin of error, Murphy said. She believes the "smallest hint" of pressure could be a significant negative catalyst for the stock. Further, the analyst notes that Amazon's (AMZN) Prime Wardrobe is now advertising in key NFL slots and that the company is testing a personalized recommendation service for certain categories. In late morning trading, Stitch Fix is lower by over 13%. COWEN CUTS SKECHERS TO MARKET PERFORM: Cowen analyst John Kernan downgraded Skechers (SKX) to Market Perform from Outperform citing growing inventory levels, particularly as foreign exchange headwinds in key markets build. He also believes consensus forecasts for operating expansion are too optimistic. Kernan lowered his price target to $28 from $32 on Skechers shares, which are down 4.7% in late morning trading. JPMORGAN CUTS GE'S PRICE TARGET: JPMorgan analyst Stephen Tusa lowered his price target for General Electric (GE) to $10 from $11 and kept an Underweight rating on the shares. The impact on "asset value" from a failure at GE's U.S. H-frame launch customer, while tough to estimate, represents a negative development for a company that has little wiggle room for more "shoes to drop," Tusa said. MORGAN STANLEY POSITIVE ON APPLE IPHONE DUAL-SIM ADDITION: In EMEA and Asia, smartphones with dual-SIM capabilities have become the status quo, noted Morgan Stanley analyst Katy Huberty, who believes that Apple adding dual-SIM to the new iPhones is an underappreciated feature with the potential to drive upside to shipments in FY19. Huberty kept an Overweight rating and $247 price target on Apple shares.
09/20/18
PIPR
09/20/18
DOWNGRADE
Target $43
PIPR
Neutral
Stitch Fix downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Erinn Murphy downgraded Stitch Fix (SFIX) to Neutral while raising her price target for the shares to $43 from $29. The analyst cites valuation for the downgrade. With shares nearing $50, market expectations do not provide any margin of error, Murphy tells investors in a research note. She believes the "smallest hint" of pressure could be a significant negative catalyst for the stock. Further, the analyst notes that Amazon's (AMZN) Prime Wardrobe is now advertising in key NFL slots and that the company is testing a personalized recommendation service for certain categories including footwear per CNBC.
WFC Wells Fargo
$55.57

0.34 (0.62%)

09/07/18
MACQ
09/07/18
DOWNGRADE
Target $63
MACQ
Neutral
Wells Fargo downgraded to Neutral on falling estimates, valuation at Macquarie
Macquarie analyst David Konrad downgraded Wells Fargo to Neutral from Buy with a $63 price target based on valuation and near-term estimates falling below expectations. Konrad said valuation has moved in line relative to peers following favorable expense guidance and the strong CCAR results and believes it will take a few more quarters before leverage drives higher earnings.
09/07/18
09/07/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA DOUBLE UPGRADES AK STEEL: BofA Merrill Lynch analyst Timna Tanners double upgraded AK Steel (AKS) to Buy from Underperform and raised its price target to $6 from $5. Tanners is now modeling 2019 spot benchmark hot rolled coil at $750/short ton versus $700 previously and expects 85% of AK Steel's sheet business that is on fixed-price contracts will have a substantial increase in 2019. In mid-morning trading, AK Steel is up 2%. MACQUARIE CUTS WELLS FARGO TO NEUTRAL: Macquarie analyst David Konrad downgraded Wells Fargo (WFC) to Neutral from Buy with a $63 price target based on valuation and near-term estimates falling below expectations. Konrad said valuation has moved in-line relative to peers following favorable expense guidance and the strong CCAR results, and believes it will take a few more quarters before leverage drives higher earnings. SUSQUEHANNA INITIATES BAIDU, JD.COM: Susquehanna analyst Shyam Patil initiated Baidu (BIDU) with a Positive rating and $325 price target, saying its a 20%+ grower with upside to estimates and the multiple with little downside risk. Patil said the company has several initiatives underway that will drive upside over the near-to-intermediate-term with longer-term AI projects that represent call options. Patil also initiated JD.com (JD) with a Neutral rating and $30 price target, saying he is concerned Alibaba (BABA) will continue to be an e-commerce category killer in China and will remain aggressive in its efforts to take share from JD. GOLDMAN RAISES APPLE TARGET TO $240: Goldman Sachs analyst Rod Hall outlined his expectations for Apple's (AAPL) new product event on September 12, stating that he expects three new iPhones at better price points. He also expects Apple to announce two new AppleCare+ Plans associated with the iPhone 9 and the Xs+ and raised his Services forecast to account for an overall mix of AppleCare+ skewed towards higher priced plans. Hall raised his price target on Apple shares to $240, but maintained a Neutral rating on the stock. BOFA DEFENDS MICRON: BofA Merrill Lynch analyst Simon Woo kept his Buy rating and $100 price target on Micron (MU), saying the fundamentals of the company's earnings remain solid, and the recent correction in the stock price is likely "sentiment related". The analyst notes that the company is still headed for "record-high revenue/profit," and the stalled rise in memory chip prices does not signal a market downturn.
09/12/18
JPMS
09/12/18
NO CHANGE
JPMS
Underweight
Reported OCC rejection would be negative for Wells, says JPMorgan
According to Reuters, Office of the Comptroller of the Currency regulators have rejected Wells Fargo's plan to repay its auto customers who were pushed to buy unnecessary auto insurance, JPMorgan analyst Vivek Juneja tells investors in a research note. This rejection would be a negative for Wells as it may be required to spend more and take more time to satisfy regulators, the analyst writes. He also views the news negatively overall for the bank's ongoing regulatory issues. Juneja reiterates an Underweight rating on shares of Wells Fargo.
09/17/18
EDJN
09/17/18
UPGRADE
EDJN
Buy
Wells Fargo upgraded to Buy from Hold at Edward Jones (Friday)
GE General Electric
$12.47

-0.39 (-3.03%)

09/14/18
JPMS
09/14/18
NO CHANGE
JPMS
Underweight
JPMorgan's Tusa advises caution after reading GE, Wabtec deal proxies
A read of the General Electric (GE), Wabtec (WAB) transportation deal proxies suggests "caution is warranted" in taking the forecasts "to the bank," JPMorgan analyst Stephen Tusa tells investors in a research note. The situation "looks eerily similar" to GE's Baker Hughes (BHGE) deal, where management went from pitching $8B in future EBITDA several years forward to "slowly pulling annual guidance once public," with a consensus that is now at $5B, Tusa writes. For good measure, the analyst calls that deal's lowered guidance "still a stretch." He believes that as each of GE's Industrial businesses get broken out clearly with "clean GAAP" transparency, the less impressive the financials look. Tusa keeps an Underweight rating on General Electric.
09/14/18
09/14/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. WELLS SAYS 'MAY BE AS GOOD AS IT GETS' FOR COSTCO: Wells Fargo analyst Edward Kelly downgraded Costco Wholesale to Market Perform from Outperform with an unchanged price target of $235. While Costco remains one of the highest quality companies within consumer and its near-term results should be positive, "this may be as good as it gets," Kelly told investors. He believes the stock's 50% rally over the past year "has left it priced for perfection" and that Costco's comps "seem destined to slow in 2019" as it laps tough comparisons. JPMORGAN ADVISE CAUTION ON GE: A read of the proxies for the General Electric (GE) and Wabtec (WAB) transportation deal suggests "caution is warranted" in taking the forecasts "to the bank," JPMorgan analyst Stephen Tusa wrote in a research note. The situation "looks eerily similar" to GE's Baker Hughes (BHGE) deal, where management went from pitching $8B in future EBITDA several years forward to "slowly pulling annual guidance once public," with a consensus that is now at $5B, Tusa said. He believes that as each of GE's Industrial businesses get broken out clearly with "clean GAAP" transparency, the less impressive the financials look. Tusa keeps an Underweight rating on General Electric shares. CORNING UPGRADED ON OPTICAL DEMAND STRENGTH: Citi analyst Asiya Merchant upgraded Corning (GLW) to Buy from Neutral with a $40 price target, telling investors that the shares are "poised to continue to grind higher" in the next 12-18 months. The analyst expects Corning's earnings and margins growth will be driving by optical demand strength and better display pricing. JPMORGAN CUTS VALVOLINE TO UNDERWEIGHT ON NEW AMAZON COMPETITION: JPMorgan analyst Jeffrey Zekauskas downgraded Valvoline (VVV) to Underweight from Neutral and lowered his price target for the shares to $20 from $22. Industry trade publication National Oil and Lube New is reporting that Amazon (AMZN) has launched its first private label motor oil called AmazonBasics Full Synthetic Motor Oil, Zekauskas noted. While too early to gauge the effects of the Amazon entry on the Valvoline brand, the new competition from Amazon will likely reduce Valvoline's trading multiple "because the lubricant industry structure is probably weaker for its entry," Zekauskas contends. NVIDIA TARGET HIKED TO $350: Needham analyst Rajvindra Gill raised his price target on Nvidia to $350 from $325 after his investor meeting with its Data Center GM and Director of IR, saying the discussions about the company's AI/ML dominance reminded him of "Wintel" platform during the PC computing era. The analyst believes that Nvidia is "uniquely positioned" to capitalize on the next wave of computing, taking a larger inference market share with its new TensorRT Hyperscaler Platform.
09/20/18
JPMS
09/20/18
NO CHANGE
Target $10
JPMS
Underweight
JPMorgan, saying 'another shoe drops,' cuts GE price target to $10
JPMorgan analyst Stephen Tusa lowered his price target for General Electric to $10 from $11 and keeps an Underweight rating on the shares. The stock closed yesterday up 19c to $12.86. The impact on "asset value" from a failure at GE's U.S. H-frame launch customer, while tough to estimate, represents a negative development for a company that has little wiggle room for more "shoes to drop," Tusa tells investors in a research note partially titled "Another Shoe Drops: H Frame Blade Failure Risks Franchise Impairment." The analyst's channel checks, which he says are now confirmed by GE Power's CEO, GE investor relations and the customer, suggest GE has experienced a failure in a first stage blade on an H-frame in one of its two initial marquee installations in the U.S., Colorado Bend. GE is minimizing the issue, referring to the problem in general as an "oxidation issue," Tusa writes. However, one channel participant the analyst talked to spoke of the break at less than 10,000 hours as "historic." Further, Tusa says the problem is material enough for Exelon (EXC) to have shut the plant down, along with the "award winning" Wolf Hollow plant for precautionary measures. The analyst believes this suggests the situation is worse than what GE says. If as bad as it seems, there should no longer be any doubt that GE Power has company-specific issues, Tusa contends. The analyst's new price target assumes weaker results at GE Power and some franchise value impact.
DIS Disney
$111.62

1.74 (1.58%)

09/06/18
TIGR
09/06/18
NO CHANGE
TIGR
Buy
Disney business acceleration to continue, says Tigress Financial
Tigress Financial analyst Ivan Feinseth kept his Buy rating on Disney, saying the company's business performance continues to accelerate thanks to "strong box office and theme park results" along with the "launch of new key digital initiatives". The analyst notes the company is also benefiting from box office dominance amid record box office revenues going into a "strong pipeline of upcoming blockbuster releases and its recent acquisition of Fox's media assets". Feinseth further points to strong consumer spending within the theme parks along with Disney's growth initiative investments in "gaming and its soon-to-be-released direct-to-consumer ESPN+ and Disney branded streaming service."
08/22/18
08/22/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. SIDOTI UPGRADES SYSTEMAX TO BUY: Sidoti analyst Anthony Lebiedzinski upgraded Systemax (SYX) to Buy from Neutral. The analyst said the recent selloff in shares is overdone and maintained a $45 price target. Systemax shares are up 10.2% in morning trading. PIPER CUTS STARBUCKS TO NEUTRAL: Piper Jaffray analyst Nicole Miller Regan downgraded Starbucks (SBUX) last night to Neutral from Overweight and lowered her price target for the shares to $53 from $60. The motivation for the downgrade was another month of U.S. checks that suggested a lack of comp performance, Miller Regan said. The analyst believes shares of Starbucks will be "range bound at best" until U.S. trends improve. She sees issues around "inconsistent results, credibility of guidance, and management transitions." Miller Regan thinks the stock has "modest downside risk." MKM BOOSTS NETFLIX TARGET TO $395: MKM Partners analyst Rob Sanderson raised his price target for Netflix (NFLX) to $395 from $390 and kept a Buy rating on the shares after updating his estimates. The analyst said his "previous caution" on the shares is "now reversed" following the recent stock price correction. His subscriber ramp expectations are "somewhat lower" in the near-to-medium term but remain unchanged in the long-term. Netflix will approach full penetration of the U.S. over time, growing to 90M subscribers by 2025, Sanderson said. He continues to see over $40 per share in earnings power at 90M U.S. and 300M international subscribers, which he projected in the 2025 timeframe. Expectations for Netflix became "somewhat elevated, but have been appropriately moderated," Sanderson contended. He called the stock a "must-own for growth managers." BAIRD SAYS STAR WARS LICENSE ADDS VISIBILITY FOR ZYNGA: Baird analyst Colin Sebastian believes the Star Wars license announced adds some visibility to Zynga's (ZNGA) out-year growth targets. The new Disney (DIS) license is a positive development for Zynga for the longer-term given the popularity of the Star Wars franchise, Sebastian said. That said, he does not expect a material contribution from new titles until 2020. As such, Sebastian kept a Neutral rating on Zynga shares. Znga shares are up 7.6% in late morning trading. PIPER SAYS FACEBOOK USERS 'UNFAZED' BY ISSUES: Piper Jaffray analyst Michael Olson said his firm's survey of 1,300 Facebook (FB) and Instagram users leaves him confident that "most are unfazed by the negative news flow." The analyst kept an Overweight rating on Facebook shares with a $200 price target.
09/18/18
LOOP
09/18/18
NO CHANGE
Target $125
LOOP
Buy
Disney expected to acquire Sky through Fox, says Loop Capital
Loop Capital analyst Alan Gould kept his Buy rating and $125 price target on Disney (DIS), saying he continues to expect the company to acquire Sky (SKYAY) through Fox (FOXA) ahead of the 5-day auction process that may begin next week. The analyst believes that Disney "can afford to overpay" for the assets that he deems to be "strategically important" to its global DTC business and expects Fox to raise its Sky bid to "at least" match the GBP14.75 per share offer from Comcast (CMCSA). Gould also raises his expected Disney FY18 EPS view by 2c to $6.95 to account for strong film results in the current quarter.
09/19/18
UBSW
09/19/18
DOWNGRADE
UBSW
Neutral
Sky downgraded to Neutral from Buy at UBS
UBS downgraded Sky (SKYAY) to Neutral while raising its price target for the shares to 1,600p from 1,500p. The firm cites valuation for the downgrade with the stock up over 70% in the last 12 months. Sky shares are pricing in high probability that Disney (DIS)/Fox (FOXA) will return with a higher offer, UBS says. It continues to believe the company is "strategically valuable" to both Disney/Fox and Comcast (CMCSA).
SKYAY Sky
$0.00

(0.00%)

09/20/18
JEFF
09/20/18
NO CHANGE
Target $44
JEFF
Buy
Jefferies boosts Comcast target to $44, reiterates as top-pick
Jefferies analyst John Janedis raised his price target for Comcast to $44 from $41 and reiterates the shares as a top-pick with a Buy rating. Sentiment on the stock should continue to improve as broadband subscriber growth and average revenue per user "remains healthy," fixed 5G is viewed as a less viable threat and as Business Services "remains a growth engine," Janedis tells investors in a research note titled "Trends in Cable Reinforce Our Positive View." He views Comcast's portfolio of assets as "unique" and believes the M&A overhang "should begin to diminish" as the Sky (SKYAY) process concludes.
07/20/18
JEFF
07/20/18
NO CHANGE
Target $41
JEFF
Buy
Comcast added to Franchise Pick List with $41 target at Jefferies
Jefferies analyst John Janedis added Comcast (CMCSA) to his firm's Franchise Pick List while keeping a Buy rating on the shares with a $41 price target. The analyst expects the "M&A driven volatility" to subside following Comcast's announcement to walk away from 21st Century Fox (FOXA). The stock remains attractively valued with the company's fundamentals "stable to improving," Janedis tells investors in a research note. He believes the outcome of Sky (SKYAY) "will not be a thesis changer" and that Comcast should see multiple expansion.
CMCSA Comcast
$37.81

0.49 (1.31%)

08/06/18
08/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Overweight from Neutral at Atlantic Equities with analyst Hamilton Faber saying he believes "the bulk of the M&A storm" has passed. 2. Qualcomm (QCOM) upgraded to Outperform from Market Perform at Cowen with analyst Matthew Ramsay citing the company's $30B buyback and saying he believes the shares offer a compelling risk/reward with effects of lower spending, solid customer performance, and potential QTL resolutions. 3. Square (SQ) upgraded to Buy from Neutral at Buckingham with analyst Chris Brendler saying the Q2 strong results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better-then-expected core revenue growth into 2020. 4. Parker-Hannifin (PH) upgraded to Outperform from In Line at Evercore ISI with analyst David Raso saying the company's recent operational struggles are behind it with this quarters report and views 2019 guidance as conservative. 5. Intercept (ICPT) upgraded to Buy from Sell at Goldman Sachs with analyst Salveen Richter saying Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CMCSK Comcast
$0.00

(0.00%)

06/26/18
BUCK
06/26/18
INITIATION
BUCK
Neutral
Sky initiated with a Neutral at Buckingham
Earlier today, Buckingham analyst Michael Harrigan initiated Sky (SKYAY) with a Neutral rating and GBP14.50 price target with 3% upside, above Comcast's (CMCSA) GBP12.50 cash bid and a premium to 21st Century Fox's (FOXA) GBP10.75 bid to buy the 61% of Sky it does not already own. The analyst tells investors in a research note that a higher bid assessment could be triggered by the U.K. Takeover Panel exercising its authority to mandate a higher takeout bid if the price paid by Comcast or Disney (DIS) to buy the 21st Century Fox assets that are in play implies a higher bid.
07/13/18
BERN
07/13/18
NO CHANGE
BERN
Bernstein 'not so sure' Comcast will give up on Fox assets
Bernstein analyst Todd Juenger said that it appears that the market is starting to believe Comcast (CMCSA) will give up on its bid to buy assets from 21st Century Fox (FOXA) and focus on Sky (SKYAY), but he said he is "not so sure" that is the case after only one counter from Disney (DIS). He does not believe Comcast would put forth a $35 bid unless it was prepared to bid up to near $45 per share, Juenger tells investors. If Comcast ups its bid, it either wins Fox at a high price or Disney is forced to pay more, which both seem better than giving up to him, Juenger stated. In any case, the "winner" will be left with increased leverage on a cyclical business late in the cycle at a time when it needs to invest significantly to build its direct-to-consumer business, added Juenger.
07/13/18
07/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. VF CORP DOUBLE UPGRADE: BofA Merrill Lynch analyst Robert Ohmes upgraded VF Corp (VFC) to Buy from Underperform and raised his price objective to $96 from $65 ahead of the company's earnings report on July 20, telling investors in a research note that he believes Vans will be a "go-to-brand" for the back-to-school selling season. He said his channel checks indicate accelerating momentum in Vans, especially classic styles, and that the $50-$60 price point is attractive given consumers' shift to value. RAYMOND JAMES DOWNGRADES AT&T: Raymond James downgraded AT&T (T) to Market Perform from Outperform. Analyst Frank Louthan said he views the Department of Justice appeal of the Time Warner case as a negative and said it is a "frustrating delay." Louthan expects the suit to be a "significant overhang" for an extended period of time, which will limit share appreciation, but remains confident AT&T will prevail. AT&T is lower by 2% in late morning trading. STIFEL STARTS GALMED WITH A BUY: Stifel analyst Adam Walsh initiated Galmed (GLMD) with a Buy rating and $35 price target, calling it a "legitimate late-stage NASH play" after Aramchol recently proved itself in a Phase 2 trial as a clearly active and "very safe" compound for treating NASH. Galmed is trading higher by over 17% in late morning trading. MORGAN STANLEY HIKES WWE TARGET TO $100: Morgan Stanley analyst Benjamin Swinburne said that WWE (WWE), by securing rights fees in its new five-year agreements with NBC (CMCSA, CMCSK) and Fox (FOX, FOXA) that are 3.6 times higher than its prior five-year broadcast agreement with NBC, has gained a "massive increase" in earnings power and "extremely high" visibility into the associated revenue. Given the recently announced deals, he raised his price target on WWE shares to $100 from $58 and kept an Overweight rating on the stock. WILLIAM BLAIR CALLS KEMPER PULLBACK 'BUYING OPPORTUNITY': William Blair analyst Adam Klauber said he views shares of Kemper (KMPR) as "even more attractive" after the recent pullback, which he attributes to selling pressures from Infinity Property shareholders receiving Kemper stock. Klauber said Kemper "continues to be our top conviction idea," and kept an Outpeform rating on the name. Kemper is higher by 4.8% in late morning trading.
07/25/18
JPMS
07/25/18
NO CHANGE
JPMS
Overweight
Invalidated patent 'not material' to TiVo court fight, says JPMorgan
JPMorgan analyst Sterling Auty noted that the USPTO's Patent Trial and Appeal Board has declared patent 8,433,696 held by TiVo (TIVO) to be invalid as it believes that the technology involves a variation of earlier know-how. While a "scary headline," the reality is this does not matter in terms of TiVo's court case with Comcast (CMCSA), since this patent was dropped from the case, said Auty, who keeps an Overweight rating on TiVo shares.
FOX 21st Century Fox
$44.20

-0.05 (-0.11%)

08/09/18
08/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Seagate (STX) downgraded to Sell from Neutral at Goldman Sachs by analyst Mark Delaney, who said that while Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market." 2. 21st Century Fox (FOXA) downgraded to Sector Perform from Outperform at RBC Capital by analyst Steven Cahall who noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. 3. e.l.f. Beauty (ELF) downgraded to Hold from Buy at Jefferies by analyst Stephanie Wissink, who said she is disappointed with the company's "sales fall off," which she says "seems more systemic than previously assumed." e.l.f.'s profit advancement will reverse in the second half of the year amid stepped up brand investment. Shares were also downgraded to Underweight from Neutral at Piper Jaffray, who said she sees a "growing risk of shelf-space cuts into 2019" if underlying sales trends do not improve, at Citi to Neutral from Buy and at DA Davidson to Neutral from Buy. 4. Southern Company (SO) downgraded to Underperform from In Line at Evercore ISI by analyst Greg Gordon, who said he believes the shares are still not discounting enough risk after the company announced a $790M after-tax charge related to an increase in the cost estimate for constructing Vogtle Nuclear Plants 3 and 4. Shares were also downgraded to Underperform from Neutral at Credit Suisse, to Equal Weight from Overweight at Barclays and to Neutral from Buy at Guggenheim. 5. Schneider National (SNDR) downgraded to Underperform from Buy at BofA/Merrill by analyst Ken Hoexter, who cited "stretched" relative valuation. The analyst also downgraded Genesee & Wyoming (GWR) to Neutral from Buy, saying recent strength in shares has led to a premium multiple and sees minimal upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/18
08/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS SEAGATE TO SELL: Goldman Sachs analyst Mark Delaney downgraded Seagate Technology (STX) to Sell from Neutral and lowered his price target for the shares to $44 from $50, representing 20% downside from current levels. While Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market," Delaney said. He believes Seagate's fundamentals will peak in the second half of 2018 and decline in 2019. RBC CUTS FOX TO SECTOR PERFORM ON VALUATION: RBC Capital analyst Steven Cahall downgraded 21st Century Fox (FOXA) to Sector Perform from Outperform, but raised his price target to $49 from $45. The analyst noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. Cahall adds that while the company is "undervalued", he awaits the separation to re-evaluate his stance. MORGAN STANLEY DOWNGRADES SEMI INDUSTRY: Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore kept Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. SOUTHERN COMPANY GETS MULTIPLE DOWNGRADES AFTER Q2 REPORT: Barclays analyst Eric Beaumont downgraded Southern Company (SO) to Equal Weight and lowered his price target for the shares to $48 from $51. Credit Suisse analyst Michael Weinstein downgraded Southern Company to Underperform from Neutral and lowered his price target on the shares to $43 from $46. Guggenheim analyst Shahriar Pourreza downgraded Southern Company to Neutral from Buy and lowered his price target on the stock to $47 from $50. Evercore ISI analyst Greg Gordon downgraded Southern Company to Underperform from In Line and lowered his price target on Southern shares to $46 from $46.75.
FOXA 21st Century Fox
$44.59

-0.01 (-0.02%)

UAA Under Armour
$20.01

1.26 (6.72%)

08/16/18
08/16/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ARGUS SAYS BUY LULULEMON: Argus analyst John Staszak upgraded Lululemon (LULU) to Buy from Hold with a price target of $150, citing the company's Q1 earnings beat and expectations of improved comps in Q2, along with its "substantial" growth opportunities to expand its brand overseas and particularly in China. Staszak contends that Lululemon's growth prospects are "among the best in the apparel sector," with a transition to higher margin e-commerce sales seen expanding its operating margins in the coming several years. The analyst further notes that his implied price target valuation multiple of 44-times forward earnings is within the multiple range of companies like Nike (NKE), Under Armour (UA), and VF Corp. (VFC) and justified by its rapid e-commerce adoption and strong overall growth. KIMBERLY-CLARK RAISED AFTER PRICE HIKES: JPMorgan analyst Andrea Teixeira upgraded shares of Kimberly-Clark (KMB) to Neutral from Underweight and raised her price target to $114 from $90 following yesterday's announcement that the company will increase prices or reduce package counts on key products in North America. The analyst notes that while it remains to be seen if the price increases will "actually hold" given the intensely competitive U.S. market, she believes investors will give Kimberly-Clark shares the benefit of the doubt. Additionally, she tells investors that Procter & Gamble's (PG) commentary that it plans to raise prices on some of its premium paper products and diapers is "supportive" of Kimberly-Clark's ability to pass on higher prices. COTY CUT TWO NOTCHES AT MERRILL: BofA Merrill Lynch analyst Olivia Tong double downgraded Coty to Underperform from Buy and cut its price target to $10 from $16. Tong said Coty is now more exposed to the mass beauty market following its merger with 41 brands from PG Beauty and is seeing disruption from smaller, niche brands and newer distribution channels. ACTIVISION PULLBACK SEEN AS OPPORTUNITY: Jefferies analyst Timothy O'Shea said he views China having frozen mobile game approvals as a temporary problem and "mostly a non-issue" as only the monetization approval process has been frozen, not the content approval process, and he notes administrators are already implementing a fast-track approval process to alleviate the problem. Activision Blizzard (ATVI) has a pipeline of new mobile games coming that he would still expect to launch in China over time and O'Shea sees the 15% pullback in the game maker's shares in the last month as a buying opportunity, he tells investors. He maintains a Buy rating and $90 price target on Activision shares.
08/29/18
BARD
08/29/18
NO CHANGE
Target $27
BARD
Outperform
Under Armour selloff on Dick's 'head fake' a buying opportunity, says Baird
Baird analyst Jonathan Komp noted that while Dick's Sporting Goods (DKS) reported its own "disappointing" earnings, the company called out continued sales challenges for Under Armour (UAA), which it attributed to expanded distribution. He believes current sporting goods disruption for Under Armour is already reflected in the company's 2018 earnings guidance and also believes other mid-tier channels have continued to show strong sales performance, pointing out that Kohl's (KSS) saw Under Armour accelerate in Q2. Komp, who views the selloff on Dick's comments a "compelling buying opportunity," keeps an Outperform rating and $27 price target on Under Armour Class A shares.
08/07/18
BARD
08/07/18
NO CHANGE
Target $27
BARD
Outperform
Under Armour designated as Fresh Pick at Baird
Baird analyst Jonathan Komp designated Under Armour shares as a Fresh Pick citing its recent pullback and stabilizing fundamentals, both which he sees supporting a good second half setup. Komp reiterated his Outperform rating and $27 price target on Under Armour shares.
08/01/18
MSCO
08/01/18
INITIATION
Target $20
MSCO
Equal Weight
Under Armour initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Lauren Cassel initiated Under Armour with an Equal Weight and $20 price target citing rich valuation.
UA Under Armour
$18.16

0.88 (5.09%)

08/16/18
ARGS
08/16/18
UPGRADE
Target $150
ARGS
Buy
Lululemon upgraded to Buy at Argus on international growth opportunity
As reported earlier, Argus analyst John Staszak upgraded Lululemon (LULU) to Buy from Hold with a price target of $150 while also raising his FY19 EPS outlook to $3.40 from $3.21. The analyst cites the company's Q1 earnings beat and expectations of improved comps in Q2, along with its "substantial" growth opportunities to expand its brand overseas and particularly in China. Staszak contends that Lululemon's growth prospects are "among the best in the apparel sector", with transition to higher margin e-commerce sales expanding its operating margins in the coming several years. The analyst further notes that his implied price target valuation multiple of 44-times forward earnings is within the multiple range of companies like Nike (NKE), Under Armour (UA), and VF Corp (VFC) and justified by its rapid e-commerce adoption and strong overall growth.
CRBP Corbus Pharmaceuticals
$7.90

2.75 (53.40%)

09/20/18
JMPS
09/20/18
NO CHANGE
Target $27
JMPS
Outperform
Corbus deal for endocannabinoid compounds makes sense, says JMP Securities
JMP Securities analyst Liisa Bayko said she is pleased with Corbus' announcement that it has licensed the exclusive worldwide rights to develop, manufacture and market drug candidates from more than 600 compounds targeting the endocannabinoid system from Jenrin. While she thinks the deal "makes a lot of strategic sense," Bayko is not yet incorporating the drug candidates into her valuation given the early stage of these assets. Bayko, who said the new assets represent potential upside, keeps an Outperform rating and $27 price target on Corbus shares.
03/13/18
CANT
03/13/18
NO CHANGE
Target $32
CANT
Overweight
Corbus Pharmaceuticals price target raised to $32 from $28 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros last night raised his price target for Corbus Pharmaceuticals to $32 following the company's Q4 results. The analyst did not find any surprises in the release and remain focused on the company's milestones in 2018. He sees 2018 as a year for execution and keeps an Overweight rating on Corbus.
09/13/18
CANT
09/13/18
NO CHANGE
Target $36
CANT
Overweight
Cantor boosts Corbus target to Street-high $36 after Roche study 'fell short'
Cantor Fitzgerald analyst Elemer Piros raised his price target for Corbus Pharmaceuticals to a Street-high $36 following abstracts from the American College of Rheumatology meeting, which is taking place in October. Among the abstracts, Phase 3 data from Roche's (RHHBY) Phase 3 systemic sclerosis study with competitive agent tocilizumab fell short on its primary endpoint in modified Rodnan skin score, Piros tells investors in a research note partially titled "Lenabasum's Gain, Following Tocilizumab's Loss." The analyst believes the results establish Corbus' lenabasum, in Phase 3 now for systemic sclerosis, as the" only compelling treatment option for patients in this rare and life-threatening disease." Further, Additionally, Piros believes lenabasum's resolution of inflammatory activity was further validated in an assessment of interferon response in patients with dermatomyositis. The analyst reiterates an Overweight rating on the shares. Corbus Pharmaceuticals in afternoon trading is up 7.5c to $5.28.
05/11/18
CANT
05/11/18
NO CHANGE
Target $32
CANT
Overweight
Corbus Pharmaceuticals current valuation attractive, says Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros reiterates an Overweight rating on Corbus Pharmaceuticals with a $32 price target following the company's Q1 results. The analyst views 2018 as a "big year for execution" with the initiation of the Phase 3 RESOLVE-1 study in systemic sclerosis, initiation of the Phase 2b study in cystic fibrosis, and initiation of the Phase 2 study in systemic lupus erythematosus. He finds the stock's current valuation attractive.
FOLD Amicus
$12.64

0.84 (7.12%)

05/08/18
JPMS
05/08/18
NO CHANGE
JPMS
Amicus lower on Pompe program commentary, says JPMorgan
JPMorgan analyst Anupam Rama attributes today's post-earnings weakness in shares of Amicus Therapeutics to "conservative commentary" on the call related to the Pompe program. The analyst, however, does not believe that the regulatory scenarios he outlined last month for the program have fundamentally changed. Nonetheless, Rama thinks commentary on the call, particularly on timing, was perceived as cautious. Amicus shares are down 7.5% to $13.49 in midday trading.
04/11/18
JPMS
04/11/18
NO CHANGE
JPMS
Overweight
Amicus risk/reward favorable into regulatory update, says JPMorgan
JPMorgan analyst Anupam Rama notes that a regulatory update for Amicus Therapeutics' Pompe program is expected in Q2. The analyst continues to like the reward/risk profile of the shares going into the update. An accelerated approval path forward is "very much on the table," based on the strength of the Phase 1/2 data, Rama tells investors in a research note. He sees "more win scenarios than lose." The analyst believes Amicus shares can rally 30%-50% should an accelerated approval path forward emerge. Rama keeps an Overweight rating on Amicus with a $19 price target.
08/17/18
CHDN
08/17/18
DOWNGRADE
CHDN
Neutral
Amicus downgraded to Neutral from Buy at Chardan
10/04/17
BOFA
10/04/17
NO CHANGE
Target $20
BOFA
Buy
Amicus price target raised to $20 from $15 at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad raised Amicus' price target to $20 from $15 saying the Phase 1/2 trial results of ATB200/AT2221 in Pompe disease were impressive. The analyst thinks the strong data justifies progression into pivotal trials and may result in an accelerated approval path. Ahmad rates Amicus a Buy.
SFIX Stitch Fix
$41.65

-5.56 (-11.78%)

09/13/18
KEYB
09/13/18
NO CHANGE
KEYB
Stitch Fix price target to $53 from $38 at KeyBanc
KeyBanc analyst Edward Yruma maintained an Overweight rating on Stitch Fix, raised his price target to $53 from $38, and raised his Q4, FY18, FY19, and FY20 EBITDA estimates. Yruma told investors in a research note released before the market open that he is increasingly confident in management's ability to grow market share at a healthy margin, and noted that the company's data science capabilities give it a unique advantage over its competitors.
09/20/18
09/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Seaspan (SSW) downgraded to Hold from Buy at Deutsche Bank with analyst Amit Mehrotra citing the recent strong performance of the shares and increased risk from the trade war between China and the U.S. 2. Bruker (BRKR) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Steve Beuchaw citing three company-specific leading indicators that he says point to a slower revenue outlook. 3. Stitch Fix (SFIX) downgraded to Neutral from Overweight at Piper Jaffray with analyst Erinn Murphy citing valuation. 4. Nutrien (NTR) downgraded to Outperform from Focus List at Scotiabank. 5. JD.com (JD) downgraded to Underperform from Outperform at CLSA with the firm lowering its price target to $29 and saying the second half will remain challenging. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
THO Thor Industries
$91.77

-13.95 (-13.20%)

05/01/18
BMOC
05/01/18
UPGRADE
Target $150
BMOC
Outperform
Thor Industries upgraded to Outperform at BMO Capital on 'overdone pullback'
As reported earlier, BMO Capital analyst Gerrick Johnson upgraded Thor Industries to Outperform from Market Perform with a price target of $150, saying that after a 30% year-to-date decline in the stock price, the pullback is "overdone". The analyst notes that the valuation is now at 8.7-times expected FY19 earnings, which is a discount to the company's historical average of 12-times. Johnson also sees the RV industry as "fundamentally sound" as more baby boomers retire and tap into their 401Ks, while younger demographic is more attracted to the outdoor lifestyle. The analyst further notes that his conversations with dealers indicate a "strong" start to 2018 sales, with consumers benefiting from tax cuts and strong economy.
05/01/18
BMOC
05/01/18
UPGRADE
BMOC
Outperform
Thor Industries upgraded to Outperform from Market Perform at BMO Capital
08/17/18
NRCS
08/17/18
NO CHANGE
NRCS
Northcoast says channel checks pointing to weakening RV demand
Northcoast analyst Seth Woolf said he has become incrementally more cautious on the Recreation & Leisure Products group as his channel checks are pointing to weakening retail demand. While he believes "the buy-side is clearly expecting to see weak wholesale numbers in the coming months," Woolf also contends that the magnitude of declines could be a surprise. He maintains a Buy rating on Camping World (CWH) and Neutral ratings on LCI Industries (LCII), Thor Industries (THO) and Winnebago (WGO).
06/07/18
RHCO
06/07/18
NO CHANGE
Target $125
RHCO
Buy
Thor Industries 'down, but not broken,' says SunTrust, cutting PT to $125
SunTrust analyst Michael Swartz told investors in a research note that Q3 was not a "banner" quarter for Thor Industries, and that while bears have "plenty to hang their hats on," shares are down, but Thor's story is "not broken." Swartz, who maintained a Buy rating but lowered his price target to $125 from $165, believes that upcoming retail data points, easing inventory and, possibly, share repurchases, could serve as near-term catalysts.
RHT Red Hat
$134.06

-9.32 (-6.50%)

09/20/18
COWN
09/20/18
NO CHANGE
Target $153
COWN
Outperform
Red Hat remains well positioned over medium to longer-term, says Cowen
Cowen analyst Gregg Moskowitz noted Red Hat reported mixed Q2 results, which was in-line with his expectations. The analyst said billings were better than feared and as a result he believes the shares are well positioned over the medium to longer-term. Moskowitz maintained his Outperform rating and lowered his price target to $153 from $160 on Red Hat shares.
09/20/18
BMOC
09/20/18
NO CHANGE
Target $158
BMOC
Market Perform
Red Hat price target lowered to $158 from $177 at BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on Red Hat to $158 and kept his Market Perform rating after its Q2 earnings miss, adding that the "solid" operating margins and "good" free cash flow in the quarter will likely be overshadowed by the worse than expected infrastructure growth rate of 8%. Despite the management's confidence in expected improved growth coming from a stronger renewal base, the analyst says his neutral stance is justified by the timing and uncertainty surrounding those expectations. Longer term, Bachman is still positive on the opportunity for Red Hat to be a "strong participant in building the hybrid cloud".
09/20/18
RBCM
09/20/18
NO CHANGE
Target $169
RBCM
Outperform
Red Hat posted another 'solid quarter', says RBC Capital
RBC Capital analyst Matthew Hedberg kept his Outperform rating and $169 price target on Red Hat after its Q2 results, saying the company produced a "solid quarter against negative sentiment" with outperformance in billings, operating margins, and earnings in spite of fewer renewals. The analyst notes that he remains confident in Red Hat's long-term opportunity, even though the company is facing short-term headwinds in middleware and portfolio renewals that is partially mitigated by cross-selling strength and large deals count.
09/20/18
OPCO
09/20/18
NO CHANGE
Target $165
OPCO
Outperform
Red Hat price target lowered to $165 from $175 at Oppenheimer
Oppenheimer analyst Ittai Kidron maintained an Outperform rating on Red Hat but lowered his price target to $165 from $175 following the company's "mixed" Q2 results. In a research note to investors, Kidron says he remains confident in Red Hat's competitive positioning, but believes it may take "a couple of quarters" to work through its issues and show more consistent growth and execution.

TODAY'S FREE FLY STORIES

ISR

IsoRay

$0.50

0.0191 (3.98%)

17:25
10/19/18
10/19
17:25
10/19/18
17:25
Syndicate
Breaking Syndicate news story on IsoRay »

IsoRay files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHS

Neuberger Berman High Yield Strategies Fd

$10.55

-0.015 (-0.14%)

17:06
10/19/18
10/19
17:06
10/19/18
17:06
Hot Stocks
Breaking Hot Stocks news story on Neuberger Berman High Yield Strategies Fd »

Saba Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOC

Biocept

$2.27

-0.04 (-1.73%)

17:04
10/19/18
10/19
17:04
10/19/18
17:04
Syndicate
Breaking Syndicate news story on Biocept »

Biocept files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$726.10

-4.09 (-0.56%)

17:03
10/19/18
10/19
17:03
10/19/18
17:03
Hot Stocks
AutoZone founder Hyde will not stand for board re-election »

AutoZone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SACH

Sachem Capital

$4.33

0.02 (0.46%)

17:03
10/19/18
10/19
17:03
10/19/18
17:03
Syndicate
Breaking Syndicate news story on Sachem Capital »

Sachem Capital files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

16:53
10/19/18
10/19
16:53
10/19/18
16:53
Conference/Events
Mirati Therapeutics to hold a conference call »

Dr. Charles Baum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SPNE

SeaSpine

$16.58

-0.54 (-3.15%)

16:47
10/19/18
10/19
16:47
10/19/18
16:47
Hot Stocks
Breaking Hot Stocks news story on SeaSpine »

First Light Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$8.76

-0.04 (-0.45%)

16:46
10/19/18
10/19
16:46
10/19/18
16:46
Conference/Events
Epizyme to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

EWI

MSCI Italy Index

$25.52

0.38 (1.51%)

, SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

16:40
10/19/18
10/19
16:40
10/19/18
16:40
General news
Breaking General news story on MSCI Italy Index, SPDR S&P 500 ETF Trust, S&P 500 »

Moody's cuts Italy…

EWI

MSCI Italy Index

$25.52

0.38 (1.51%)

SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTC

Astrotech

$2.93

-0.02 (-0.68%)

16:39
10/19/18
10/19
16:39
10/19/18
16:39
Hot Stocks
Breaking Hot Stocks news story on Astrotech »

Winn Interests reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$15.43

-1.075 (-6.52%)

16:38
10/19/18
10/19
16:38
10/19/18
16:38
Conference/Events
CytomX Therapeutics to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

ICLK

iClick Interactive Asia

$3.41

(0.00%)

16:36
10/19/18
10/19
16:36
10/19/18
16:36
Hot Stocks
Breaking Hot Stocks news story on iClick Interactive Asia »

LIM Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGLS

Tecnoglass

$9.72

(0.00%)

16:35
10/19/18
10/19
16:35
10/19/18
16:35
Syndicate
Breaking Syndicate news story on Tecnoglass »

Tecnoglass files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

16:30
10/19/18
10/19
16:30
10/19/18
16:30
Options
Preliminary option volume of 24.7M today »

Preliminary option volume…

OXM

Oxford Industries

$81.36

-1.68 (-2.02%)

16:28
10/19/18
10/19
16:28
10/19/18
16:28
Conference/Events
Oxford Industries management to meet with Sidoti »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HELE

Helen of Troy

$120.52

0.31 (0.26%)

16:26
10/19/18
10/19
16:26
10/19/18
16:26
Conference/Events
Helen of Troy management to meet with Sidoti »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CGA

China Green

$0.74

0.0584 (8.57%)

16:21
10/19/18
10/19
16:21
10/19/18
16:21
Hot Stocks
China Green receives NYSE notice regarding late Form 10-K filing »

China Green Agriculture…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
10/19/18
10/19
16:20
10/19/18
16:20
Options
Closing CBOE SPX and VIX Index summary for October 19th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:20
10/19/18
10/19
16:20
10/19/18
16:20
Conference/Events
Morgan Stanley energy analyst to hold an analyst/industry conference call »

Refining & Canadian…

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

16:20
10/19/18
10/19
16:20
10/19/18
16:20
Hot Stocks
Bristol-Myers updates on use of Opdivo and Yervoy in first-line lung cancer »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
10/19/18
10/19
16:17
10/19/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNGO

Bionano Genomics

$6.98

0.08 (1.16%)

16:17
10/19/18
10/19
16:17
10/19/18
16:17
Hot Stocks
Bionano Genomics and GrandOmics partner to offer genetic test for FSHD in China »

Bionano Genomics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

$30.73

-0.2 (-0.65%)

16:16
10/19/18
10/19
16:16
10/19/18
16:16
Hot Stocks
Holly Energy Partners raises quarterly distribution to 66.5c from 66c per unit »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

SES

Synthesis Energy Systems

$1.70

-0.075 (-4.23%)

16:16
10/19/18
10/19
16:16
10/19/18
16:16
Hot Stocks
Synthesis Energy Systems receives non-compliance letter from Nasdaq »

Synthesis Energy Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
10/19/18
10/19
16:16
10/19/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.